Mangoceuticals (MGRX) Equity Ratio (2022 - 2025)
Mangoceuticals' Equity Ratio history spans 4 years, with the latest figure at 0.94 for Q4 2025.
- On a quarterly basis, Equity Ratio rose 4.13% to 0.94 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.94, a 4.13% increase, with the full-year FY2025 number at 0.94, up 4.13% from a year prior.
- Equity Ratio hit 0.94 in Q4 2025 for Mangoceuticals, down from 0.95 in the prior quarter.
- Over the last five years, Equity Ratio for MGRX hit a ceiling of 0.95 in Q3 2025 and a floor of 3.18 in Q1 2024.
- Historically, Equity Ratio has averaged 0.57 across 4 years, with a median of 0.91 in 2023.
- Biggest five-year swings in Equity Ratio: plummeted 442.61% in 2024 and later surged 129.28% in 2025.
- Tracing MGRX's Equity Ratio over 4 years: stood at 0.61 in 2022, then increased by 20.47% to 0.74 in 2023, then grew by 23.05% to 0.91 in 2024, then grew by 4.13% to 0.94 in 2025.
- Business Quant data shows Equity Ratio for MGRX at 0.94 in Q4 2025, 0.95 in Q3 2025, and 0.92 in Q2 2025.